Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis-Reference-Cited by-同舟云学术

Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis

Published:2019-08-12 Issue:11 Volume:54 Page:1801-1810
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Caceres Guido Paulo¹^ORCID,Perez Mariel²,Halac Alicia³,Ferrari Mariela³,Ibarra Manuel⁴,Licciardone Nieves⁵,Castaños Claudio⁶,Gravina Luis P.⁷,Jimenez Cristina³,Garcia Bournissen Facundo⁸,Schaiquevich Paula¹⁹

Affiliation:

1. Clinical Pharmacokinetics UnitHospital de Pediatria JP Garrahan Buenos Aires Argentina

2. Pharmacy AreaHospital de Pediatria JP Garrahan Buenos Aires Argentina

3. Intermediate and Moderate Care WardHospital de Pediatria JP Garrahan Buenos Aires Argentina

4. Pharmaceutical Sciences, Department of ChemistryUniversidad de la Republica Uruguay Uruguay

5. Laboratory ServiceHospital de Pediatria JP Garrahan Buenos Aires Argentina

6. Department of PulmonologyHospital de Pediatria JP Garrahan Buenos Aires Argentina

7. Molecular Biology – GeneticsHospital de Pediatria JP Garrahan Buenos Aires Argentina

8. Multidisciplinary Institute for Pediatric Pathology Research (IMIPP)Hospital General de Niños R Gutierrez Argentina

9. National Scientific and Technical Research Council (CONICET) Buenos Aires Argentina

Funder

Ministerio de Salud de la Nación

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24468

Reference41 articles.

1. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary

2. Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

3. Managing Cystic Fibrosis

4. Once daily dosing of aminoglycosides in pediatric cystic fibrosis patients: a review of the literature;Wassil SK;J Pediatr Pharmacol Ther,2008

5. Amikacin target achievement in adult cystic fibrosis patients utilizing Monte Carlo simulation

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative assessment of trough and peak levels and AUC24 for amikacin in nontuberculous mycobacterial infection;Clinica Chimica Acta;2025-01

2. Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence;Microbiology Spectrum;2024-02-06

3. Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation;Frontiers in Pharmacology;2023-03-09

4. Defining the Importance of Age-Related Changes in Drug Clearance to Optimizing Aminoglycoside Dosing Regimens for Adult Patients with Cystic Fibrosis;European Journal of Drug Metabolism and Pharmacokinetics;2021-12-09

5. A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic Fibrosis;Therapeutic Drug Monitoring;2021-08